Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice

Abstract excerpt

Since the first identification of CTNNB1 mutations in adamantinomatous craniopharyngioma (ACP), much has been learned about the molecular pathways and processes that are disrupted in ACP pathogenesis. To date this understanding has not translated into tangible patient benefit. The recent development of novel techniques and a range of preclinical models now provides an opportunity to begin to support treatment...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chromatin Remodeling and Cancer
• Share to Hedgehog Signaling Pathway Studies
• Share to Pituitary Gland Disorders and Treatments